Trademark Overview
On Thursday, September 28, 2023, a trademark application was filed for EPSTEIN-BARR VIRUS TOGETHER with the United States Patent and Trademark Office. The USPTO has given the EPSTEIN-BARR VIRUS TOGETHER trademark a serial number of 98202968. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, May 29, 2024. This trademark is owned by Epstein-Barr Virus Together, Inc.. The EPSTEIN-BARR VIRUS TOGETHER trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Education & Entertainment Services categories with the following description:
Educational services in the nature of classes, seminars, forums, workshops, conferences and programs in the field of Epstein-Barr virus research, education, and funding Epstein-Barr virus research, and distributing educational materials in connection therewith; publication of educational materials, namely, brochures and fact sheets for use in connection with educational services in the nature of classes, seminars, forums, workshops, conferences and programs in the field of Epstein-Barr virus research, education, and funding Epstein-Barr virus research; providing on-line publications in the nature of brochures, fact sheets, frequently asked questions, webinars and audio-visual recordings in the field of Epstein-Barr virus research, education, and funding Epstein-Barr virus research
Charitable fundraising services; charitable fundraising to support public advocacy and promoting public awareness of Epstein-Barr virus research, treatments and education; charitable fundraising to support education and medical research concerning Epstein-Barr virus awareness, detection, treatment and cure; charitable fundraising to support public advocacy for Epstein-Barr virus research funding
Providing public advocacy and promoting public awareness of Epstein-Barr virus research, treatments and education and advocate for Epstein-Barr virus research funding; promoting public interest in Epstein-Barr virus research, treatment and education; lobbying services, namely, promoting the interests of Epstein-Barr virus research and awareness programs in the fields of legislation and regulation